[Double-blind evaluation of a combined oxazepam hemisuccinate-hexadiphane treatment versus hexadiphane in the therapy of visceral spastic syndromes].
D000328:Adult; D000368:Aged; D001381:Azepines / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010076:Oxazepam / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D013035:Spasm / Q000188:drug therapy
D001381:Azepines; D001555:Benzene Derivatives; D004338:Drug Combinations; D010076:Oxazepam
Valutazione in doppio cieco di un trattamento combinato oxazepam emisuccinato-esadifano versus esadifano nella terapia di sindromi spastiche viscerali